why choose us

First received: June 27, 2023

Clinical Trial: First-in Human Phase I Study of ISM3091 in Patients With Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ISM3091 in Patients With Advanced Solid Tumors

Brief Summary: This is a first-in-human, multicenter, open-label Phase I study.The study will be comprised of a dose escalation part followed by a dose selection optimization part.

Read more